We're building dbTwin to make inter-company exchange of sensitive data in biopharma a whole lot easier.

We're looking to partner with translational teams to continue validating our tech, which has shown that synthetic data faithfully replicates complex biological signals, offering a privacy-secured path for the future of genomic research.